Marksans Pharma Q4 Results Live : profit falls by 4.44% YOY
Marksans Pharma Q4 Results Live : Revenue increased by 15.23% YoY & profit decreased by 4.44% YoY
Stay updated with breaking news from Marksans Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Marksans Pharma Q4 Results Live : Revenue increased by 15.23% YoY & profit decreased by 4.44% YoY
Fourth quarter earnings season is wrapping up with 895 companies reporting results on Thursday. Investors keenly await Apollo Hospitals' results, expecting robust growth driven by improved ARPOB and HealthCo operations. Analysts predict up to a 68% YoY increase in net profit, with sales expected to rise by 13%.
Indian shares fell for a fifth straight session on Thursday, pressured by weakness in global peers, while some investors trimmed positions ahead of federal election results. The NSE...
Marksans Pharma received the UK health regulator's nod to market its new oral solution for epilepsy patints.
Kenneth Andrade anticipates significant growth in the power market, emphasizing massive investments in energy capex equivalent to India's GDP over the next 15 years. He discusses the impact on various sectors and the rationale behind his pharma holdings, focusing on profitability potential. Andrade says he is avoiding banks because he chooses to be on the asset side and not on the liability side.